Unknown

Dataset Information

A new polysaccharide platform constructs self-adjuvant nanovaccines to enhance immune responses.


ABSTRACT:

Background

Nanovaccines have shown the promising potential in controlling and eradicating the threat of infectious diseases worldwide. There has been a great need in developing a versatile strategy to conveniently construct diverse types of nanovaccines and induce potent immune responses. To that end, it is critical for obtaining a potent self-adjuvant platform to assemble with different types of antigens into nanovaccines.

Results

In this study, we identified a new natural polysaccharide from the rhizomes of Bletilla striata (PRBS), and used this polysaccharide as a platform to construct diverse types of nanovaccines with potent self-adjuvant property. In the construction process of SARS-CoV-2 nanovaccine, PRBS molecules and RBD protein antigens were assembled into ~ 300 nm

SUBMITTER: Chen S 

PROVIDER: S-EPMC9281129 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature